Prelude Therapeutics Balance Sheet (2019-2026) | PRLD

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
61.42M35.87M55.68M54.75M56.07M34.65M22.25M30.49M19.94M29.34M28.75M31.87M15.18M16.52M44.31M77.30M47.53M35.26M84.80M155.20M
Short-term Investments (Quarter)
259.44M259.40M214.56M195.60M172.02M171.12M154.05M228.54M214.61M207.64M177.22M152.02M142.49M121.14M58.80M47.46M7.42M67.96M59.80M125.43M
Cash & Current Investments (Quarter)
320.87M295.28M270.23M250.35M228.09M205.77M176.30M259.03M234.55M236.98M205.97M183.89M157.67M137.66M103.12M124.76M54.96M103.21M144.60M280.63M
Prepaid Assets (Quarter)
5.03M3.88M3.78M2.32M2.85M2.65M3.01M5.22M4.41M2.65M3.44M2.87M2.76M2.28M3.33M3.66M3.37M2.48M3.04M3.14M
Current Assets (Quarter)
325.90M295.12M269.97M248.62M226.89M204.38M175.26M260.21M234.92M235.59M205.37M182.71M156.39M135.90M102.40M76.88M58.33M105.69M84.59M154.90M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
3.21M3.93M4.12M4.29M5.11M4.91M5.37M6.08M6.62M7.33M7.29M7.55M7.20M6.77M6.39M5.96M5.53M5.11M4.72M4.40M
Other Non-Current Assets (Quarter)
0.30M0.31M4.04M4.93M5.38M4.04M4.04M12.47M0.29M0.29M0.41M0.41M0.11M4.04M4.04M3.23M0.11M3.23M3.40M
Non-Current Assets (Quarter)
5.32M9.98M10.70M10.43M15.43M16.12M23.06M20.40M23.59M42.08M41.74M41.58M40.83M39.62M38.86M38.04M36.42M35.62M35.05M34.47M
Assets (Quarter)
331.22M305.10M280.67M259.06M242.33M220.50M198.32M280.61M258.51M277.67M247.11M224.29M197.22M175.51M141.26M114.92M94.75M141.31M119.64M189.36M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
11.06M7.84M7.39M6.27M10.25M6.78M7.08M5.58M5.17M4.58M5.31M6.17M5.92M7.73M5.83M4.96M2.53M3.98M2.07M2.03M
Payables (Quarter)
11.06M7.84M7.39M6.27M10.25M6.78M7.08M5.58M5.17M4.58M5.31M6.17M5.92M7.73M5.83M4.96M2.53M3.98M2.07M2.03M
Accumulated Expenses (Quarter)
6.76M9.62M3.02M4.03M9.92M13.09M11.19M5.04M6.98M15.77M3.64M5.64M7.59M9.02M11.30M13.23M6.49M12.53M5.94M7.98M
Other Accumulated Expenses (Quarter)
0.57M0.09M0.35M0.29M0.17M0.52M0.89M0.81M0.82M0.94M0.80M0.46M0.80M0.77M0.70M0.86M0.96M0.96M0.91M0.63M
Current Leases (Quarter)
1.84M1.74M1.86M1.82M1.39M1.83M1.39M0.94M0.47M1.48M2.19M2.23M2.37M0.21M2.60M2.73M2.74M2.76M2.78M
Current Deferred Revenue (Quarter)
3.00M33.73M30.95M25.25M
Total Current Liabilities (Quarter)
19.66M19.20M16.07M15.81M21.56M21.70M19.66M15.19M16.89M21.83M17.64M23.34M22.22M25.64M19.79M20.91M18.19M52.99M41.72M38.04M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
1.80M
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
0.31M0.39M16.89M15.45M15.46M15.41M15.32M15.27M15.21M15.13M15.04M14.96M14.87M
Other Non-Current Liabilities (Quarter)
2.40M2.40M3.36M3.36M3.36M3.36M3.36M3.34M3.28M3.21M3.15M3.09M3.03M2.97M2.90M2.84M2.78M2.72M
Total Non-Current Liabilities (Quarter)
19.20M16.46M15.81M21.56M21.70M19.66M15.19M16.89M37.24M33.09M38.80M37.64M40.97M35.05M36.11M33.32M69.84M56.68M52.91M
Total Liabilities (Quarter)
19.98M19.20M18.86M18.21M24.92M25.06M23.02M18.55M20.25M40.58M36.37M42.02M40.79M44.06M38.08M39.08M36.22M72.68M59.46M55.63M
Shareholder's Equity
Common Equity (Quarter)
311.24M285.90M261.81M240.84M217.41M195.44M175.30M262.06M238.26M237.09M210.73M182.28M156.43M131.46M103.18M75.84M58.53M68.64M60.18M133.73M
Liabilities and Shareholders Equity (Quarter)
331.22M305.10M280.67M259.06M242.33M220.50M198.32M280.61M258.51M277.67M247.11M224.29M197.22M175.51M141.26M114.92M94.75M141.31M119.64M189.36M
Retained Earnings (Quarter)
-186.28M-0.71M-2.31M-275.96M-305.90M-334.56M-0.40M-0.71M-423.30M-456.39M-487.82M-522.60M-554.83M-583.56M0.01M-646.90M0.00M-683.06M-693.45M-707.40M
Treasury Shares (Quarter)
0.72M0.61M0.51M0.36M0.27M0.20M0.16M0.12M0.11M0.10M0.09M0.08M0.07M0.06M0.38M0.34M0.29M0.22M0.44M0.42M